James is the co-chair of the capital markets and public companies group and concentrates his practice on corporate and securities law, representing technology and life sciences companies of international prominence in a wide range of corporate matters. He has extensive experience in capital markets transactions and has represented issuers, underwriters and other parties in a variety of public and private offerings of both equity and debt securities, including some of the most high-profile technology public offerings in history. Jamie has led or co-led offerings that have raised over $40 billion of aggregate proceeds. In addition, he regularly advises on mergers and acquisitions and related securities law issues and provides ongoing advice to both public and private companies on general corporate compliance, SEC reporting and governance issues.

Jamie is active in the Seattle and Silicon Valley business communities, regularly speaking on corporate finance topics, including initial public offerings, other corporate finance and capital formation issues and SEC regulation. He was recognized as a Washington "Super Lawyer" in the area of securities and corporate finance for 2016 – 2019, and was also named a "Rising Star" in 2012. In 2014, Jamie was named among the top attorneys in the United States under the age of 40 by Law360.

For five consecutive years (2016 – 2020), Jamie has been highlighted by The Legal 500 as among the leading lawyers in U.S. capital markets. The firm as a whole consistently ranks in Tier 1 of Legal 500's technology transactions and venture capital and emerging companies categories. Fenwick is also recognized as a leading law firm for capital markets work.

Jamie began his career at a prestigious international law firm, where he focused primarily on public offerings and mergers and acquisitions.

Read More

  • Representative Initial Public Offerings
    • Bill.com's $216M IPO
    • Peloton Interactive's $1.2B IPO
    • Smartsheet’s $175M IPO
    • Redfin's $159.2M IPO
    • Zuora’s $177.1M IPO
    • ProNAi Therapeutics’ $158.4M IPO
    • Fitbit’s $732M IPO
    • New Relic’s $115M IPO
    • LendingClub’s $1B IPO
    • Facebook’s $16B IPO
    • King Digital Entertainment’s $499.5M IPO (and its $5.9B acquisition by Activision Blizzard)
    • Veeva Systems’ $300M IPO
    • Tableau Software’s $292M IPO
    • Fusion-io’s $268M IPO
    • Nutanix’s $238M IPO
    • Green Dot’s $188M IPO
    • Jive Software’s $185M IPO
    • Model N’s $120M IPO
    • Rocket Fuel’s $116M IPO
    • New Relic’s $115M IPO
    • Zillow’s $79M IPO
    • Boingo Wireless’ $77M IPO
    • Trupanion’s $71.3M IPO
    • Underwriters in Farfetch’s $1.01B IPO
    • Underwriters in Cloudflare’s $525M IPO
    • Underwriters in Pivotal’s $638.25M IPO
    • Underwriters in Adaptive Biotechnologies' $345M IPO
  • Representative Other Capital Markets Transactions
    • Redfin’s $258.3M public offering
    • Zillow’s $747.5M follow-on offering
    • Fitbit’s $493M follow-on offering
    • Facebook’s $3.8B follow-on offering
    • Symantec’s $1.1B senior notes offering
    • Tableau Software’s $575M follow-on offering
    • Zillow’s $473M follow-on offering
    • Rocket Fuel’s $350M follow-on offering
    • Fusion-io’s $291M follow-on offering
    • Green Dot’s $260M follow-on offering
    • Zillow’s $197M follow-on offering
    • Extreme Networks' $100M tender offer
    • ZymoGenetics’ $96.6M follow-on offering
    • OncoGenex Pharmaceuticals’ $57M shelf offering
    • Dexcom’s $48M public offering

Representative Clients

  • Achieve Life Sciences
  • Amnis
  • Bill.com
  • Cascadian Therapeutics
  • Citigroup Global Markets
  • Cray
  • Credit Suisse
  • Data Domain
  • Deutsche Bank Securities
  • Dexcom
  • Facebook
  • Farfetch
  • Fitbit
  • Goldman Sachs
  • Green Dot
  • Infinia
  • Jam City
  • King Digital Entertainment
  • LendingClub
  • Madrona Venture Group
  • Morgan Stanley
  • OncoGenex
  • OVP Venture Partners
  • Peloton
  • Redfin
  • Seagate
  • Smartsheet
  • SonoSite
  • Symantec
  • Tekmira Pharmaceuticals
  • Trupanion
  • UBS AG
  • Xeround
  • ZymoGenetics

Education & Admissions

J.D., University of California, Berkeley, School of Law
Member of the Berkeley Technology Law Journal

B.A., Trinity College

Admitted to practice in California, Washington and the District of Columbia

Login

Don’t have an account yet?

Register